Earnings Call Summary | Weave Communications(WEAV.US) Q1 2024 Earnings Conference
Earnings Call Summary | Weave Communications(WEAV.US) Q1 2024 Earnings Conference
The following is a summary of the Weave Communications, Inc. (WEAV) Q1 2024 Earnings Call Transcript:
以下是Weave Communications, Inc.（WEAV）2024年第一季度财报电话会议记录摘要：
Financial Performance:
财务业绩：
Weave Communications reported Q1 2024 revenue of $47.2 million, a growth of 19.2% year-over-year, which made it the ninth quarter for them surpassing the top end of their revenue guidance.
The gross margin marked at 70.4%, has surpassed their goal of over 70%.
There is an improvement in adjusted EBITDA margin from a negative 7.9% in the previous year to a negative 0.8%.
Projected total revenue for 2024 lies within the range of $197 million to $200 million along with a non-GAAP operating loss between $6 million to $2 million.
Weave Communications报告称，2024年第一季度收入为4,720万美元，同比增长19.2％，这是他们超过收入预期最高水平的第九个季度。
毛利率为70.4％，已超过70％的目标。
调整后的息税折旧摊销前利润率从上一年的负7.9％提高到负0.8％。
2024年的预计总收入在1.97亿美元至2亿美元之间，非公认会计准则的营业亏损在600万至200万美元之间。
Business Progress:
业务进展：
Growth has been observed across verticals with specialty medical being the fastest-growing segment.
Weave has built partnerships and integrations with Athenahealth, IDEXX, Patterson Veterinary, DrChrono, and Prompt EMR, to improve market fit and efficiency.
First quarter progress showcased in the G2 Spring 2024 report for customer service and being named in the top 50 software product for small businesses.
Plans for 2024 include revenue growth through expansion in dental, optometry, veterinary verticals and growth in specialty medical markets.
各垂直领域都出现了增长，其中专业医疗是增长最快的细分市场。
Weave已与Athenahealth、IDEXX、Patterson Veterinary、drChrono和Prompt EMR建立了合作伙伴关系和整合关系，以提高市场契合度和效率。
2024年春季G2客户服务报告显示了第一季度的进展，并被评为小型企业软件产品前50名。
2024年的计划包括通过扩张牙科、验光、兽医垂直行业以及特殊医疗市场的增长来实现收入增长。
More details: Weave Communications IR
更多详情： Weave 通信 IR
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多详情，请访问投资者关系网站。本文仅供投资者参考，不构成任何投资建议。
译文内容由第三方软件翻译。